HCID 68605990, compound → HCID 10324487, compound

Participants

Reaction Steps

A method similar to the one described for (97) was used except that (2,3-cis)-3-amino-2-phenyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one hydrobromide (9d) (105 mg) was used as the amine component and N-[(3,5-difluorophenyl)acetyl]-L-leucine (108b) (85 mg) was used as the acid component to afford the title compound as a 1:1 mixture with the 2S,3S diastereomer (107 mg), white solid, m.p.180-190° C. 1H NMR (300 MHz, d6-DMSO) δ 4.76 (t, 1H, J=7 Hz), 5.12 (d, 1H, J=7 Hz), 6.91-7.49(m, 12H), 7.67 (d, 1H, J=7 Hz), 8.25 (s, 1H),10.49 (s, 1H). MS APCI, m/z=538(M+1). LC/MS: 2.65 min.

Provenance & Evidence